The global hemostasis products market is poised for significant growth in the coming decade, according to the latest market projections. Valued at USD 1.58 billion in 2023, the market is anticipated ...

Sysmex Corporation has established a new subsidiary in Nairobi, Kenya, to support growing demand for healthcare diagnostics in East Africa and strengthen its presence on the continent. The move is ...

PARIS, April 01, 2025 (GLOBE NEWSWIRE) -- Sysmex’s PA-100 AST System is redefining standard of care for diagnosing and treating urinary tract infections (UTIs). By combining cutting-edge ...

By lowering AT, a protein that inhibits blood clotting, Qfitlia helps increase thrombin generation to restore hemostasis in people with hemophilia. Qfitlia uses small-interfering RNA technology ...

"By targeting antithrombin, which can be reliably measured with an FDA-cleared blood assay, Qfitlia is proven to help rebalance hemostasis and improve bleed rates and protection.” The fitusiran ...

In addition to their essential role in hemostasis and thrombosis, platelets also modulate inflammatory reactions and immune responses. This is achieved by specialized surface receptors as well as ...

Genetic studies 11 observed relatively common polymorphisms in this protein, one of which (Marburg 1) showed diminished activity in pro-urokinase activation. The present study by Willeit et al 6 ...